Zego Becomes First Company to List on LSE’s New Private Market Platform

Zego, a London‑based insurtech startup that raised $100 million in a Series B round, will be the first company to list shares on the London Stock Exchange’s newly launched private market, aiming to tap a broader pool of institutional investors while retaining private‑company flexibility.

Yapily Turns Profitable on £16.7M Revenue, Opts Out of Open Banking Consolidation Race

Yapily, a UK‑based open banking infrastructure startup backed by Lakestar, posted a revenue increase from £6.7 million to £16.7 million and a swing to a £355,000 profit in 2025. CEO Stefano Vaccino said the company will remain on the sidelines of the sector’s consolidation, focusing on organic growth, and noted that the firm has not raised new capital since its $51 million Series B in 2021.

Birmingham-based StudyStash acquired by Kortext in strategic edtech deal

StudyStash, an AI‑driven adaptive learning platform founded by University of Birmingham alumni, has been acquired by UK‑based edtech leader Kortext. The deal, terms undisclosed, adds the platform to Kortext’s portfolio and expands its AI strategy across Europe, North America and other markets. StudyStash will continue operating as a distinct brand with its founders remaining in leadership roles, while the team relocates to Silicon Valley to grow its US presence.

London AI Recruiting Platform Metaview Raises €53.1 Million in Series C Round

London‑based AI recruiting platform Metaview announced a €53.1 million Series C round, bringing its total funding to €97.4 million. The round, led by Insight Partners with participation from GV and other investors, will fund product expansion, team growth to 250 staff, and a new New York office.

London AI Drug Discovery Startup Basecamp Research Closes $140M Series C Round

Basecamp Research, a London‑based AI life‑sciences startup founded in 2019, closed a $140 million Series C round led by S32, with participation from Nvidia, Anthropic and several European and UK investors. The funding will be used to develop next‑generation AI models and push its AI‑designed therapeutic pipeline toward clinical development.

UK Deep-Tech Startup StandardX Secures £10 Million Seed Funding to Address Global Rare Isotope Shortage

StandardX, a UK deep‑tech startup founded in 2025, secured £10 million in seed capital led by Vsquared Ventures to build a novel accelerator platform that can produce a range of rare isotopes for cancer diagnostics, targeted therapies and fusion energy, aiming to create a resilient European supply chain for these critical materials.